Not only cancer progression, but also tumor size, lymph node metastasis, and shorter overall survival of cancer patients were found to be associated with MALAT1 up-regulation [20–22]. This evidence concerns the gene MALAT1 and metastatic malignant neoplasm in the lymph nodes.